Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-09T20:21:50.047Z Has data issue: false hasContentIssue false

76 - Naratriptan

Published online by Cambridge University Press:  05 October 2012

Howard S. Smith  and
Marco Pappagallo
Edited in consultation with
Stephen M. Stahl
Howard S. Smith
Affiliation:
Academic Director of Pain Management, Albany Medical College
Marco Pappagallo
Affiliation:
Director, Pain Management and Medical Mentoring, New York Medical Home for Chronic Pain
Stephen M. Stahl
Affiliation:
University of California, San Diego
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Essential Pain Pharmacology
The Prescriber's Guide
 , pp. 355 - 357
Publisher: Cambridge University Press
Print publication year: 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Dodick, DLipton, RBMartin, VTriptan Cardiovascular Safety Expert Panel: Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraineHeadache 2004 44 414Google Scholar
Dulli, DANaratriptan: an alternative for migraineAnn Pharmacother 1999 33 704Google Scholar
Ferrari, MDRoon, KILipton, RBGoadsby, PJOral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trialsLancet 2001 358 1668Google Scholar
Gladstone, JPGawel, MNewer formulations of the triptans: advances in migraine managementDrugs 2003 63 2285Google Scholar
Lambert, GAPreclinical neuropharmacology of naratriptanCNS Drug Rev 2005 11 289Google Scholar
Mannix, LKSavani, NLandry, SEfficacy and tolerability of naratriptan for short-term prevention of menstrually related migraine: data from two randomized, double-blind, placebo-controlled studiesHeadache 2007 47 1037Google Scholar
Massiou, HNaratriptanCurr Med Res Opin 2001 17 s51Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×